Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 30, 2012. The report serves as a notification of transactions involving directors or persons discharging managerial responsibility (PDMR) and their connected persons, rather than a comprehensive financial results report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on specific share option exercises and sales by a PDMR.
Material Changes
No material changes to the company's financial position or operations are reported in this document. The only reported activity is the exercise of share options and subsequent sale of shares by Mr. P Thomson and his connected person, Mrs. K Thomson, on November 28, 2012.
Management Commentary and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It strictly details a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a) and (c).
Key Facts for Investor Verification
- Transaction Date: November 28, 2012.
- Individuals Involved: Mr. P Thomson (PDMR) and Mrs. K Thomson (Connected Person).
- Option Details: Options granted on December 3, 2002, under the GlaxoSmithKline Share Option Plan at an exercise price of £11.79 per share.
- Transaction Volume: Mr. Thomson exercised options for 6,000 shares; Mrs. Thomson exercised options for 4,500 shares.
- Sale Prices: Shares were sold at £13.365 per share (Mr. Thomson) and £13.35 per share (Mrs. Thomson).
- Notification Date: The company was advised of the transaction on November 29, 2012.